A Randomised Comparative Study of Topical Calcipotriol (0.005%) Vs Topical Calcipotriol (0.005%) along with NBUVB Phototherapy in Patients of Alopecia Areata

DEPARTMENT OF SKIN AND VD0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of any age > 5 yrs, showing features of alopecia areata
•- Patients with a diagnosis of patch type alopecia areata or alopecia totalis
•- No evidence of regrowth present at baseline.
•- Patient should be free from other modalities of treatment atleast for two weeks.

•- Patients with a history of or active skin disease on the scalp such as psoriasis or seborrheic dermatitis.
•- Patients in whom the diagnosis of alopecia areata is in question.
•- Patients with active medical conditions and other comorbid conditions like infection, eczematization that in the opinion of the investigator would alter the outcome of study evaluation.
•- Patients with history or evidence of hematopoietic abnormality
•- Patients with history or evidence of renal or hepatic impairment.
•- Patients with history of immunosuppression or history of recurrent serious infections.
•- History of photodermatitis or photosensitivity
•- Patients taking oral corticosteroids or applying topical corticosteroids or treatment from outside.
•- Patients with allergy to any component of calcipotriol preparation

发起方

DEPARTMENT OF SKIN AND VD